Back to Trades
Total Value
$1.2M
Filing Date
Jul 17, 2026
1 transaction
Trade Summary
On Jul 16, 2026, Kohler Terry, Insider, reported $1.2M of ADMA BIOLOGICS, INC. (ADMA) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $8.81. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- ADMA BIOLOGICS, INC.
- Ticker Symbol
- ADMA
- CIK
- 0001368514
Insider Information
- Name
- Kohler Terry
- Role
- Insider
- Location
- BOCA RATON, FL
Filing Details
- Filing Date
- Jul 17, 2026
- Transaction Date
- Jul 16, 2026
- Accession Number
- 0001140361-26-028844
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 16, 2026 | Common Stock | 85,130 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 16, 2026 | ADMA derivative | 136,363 | $8.81 | Grant/Award | $1.2M |
Want live alerts when Kohler Terry trades again?
Download Insider Trades to track ADMA, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)These shares represent restricted stock units ("RSUs") that will vest quarterly on each annual anniversary of the date of grant over four years in accordance with the ADMA Biologics, Inc. 2022 Equity Compensation Plan (the "Plan"), subject to the Reporting Person's continued service as of the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- (F2)Includes, as of the transaction date, (i) 85,130 unvested RSUs granted on July 16, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; and (ii) 58,019 unvested RSUs granted on December 8, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- (F3)This option was granted to the Reporting Person on July 16, 2026, and will vest over four years, with 25% of the shares subject to the option vesting on the one-year anniversary of the date of grant, and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, becoming fully vested on July 16, 2030 in accordance with the Plan, subject to the Reporting Person's continued service as of the applicable vesting date.